| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,702 |
4,289 |
$273K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,340 |
1,256 |
$124K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,721 |
2,287 |
$82K |
| 92587 |
|
1,559 |
1,544 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
905 |
869 |
$46K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
503 |
503 |
$42K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
352 |
352 |
$32K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,713 |
2,707 |
$25K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
950 |
914 |
$23K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
260 |
259 |
$22K |
| 99051 |
|
1,183 |
1,134 |
$20K |
| 90461 |
|
691 |
688 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,297 |
2,249 |
$17K |
| 99173 |
|
804 |
804 |
$16K |
| 36416 |
|
1,035 |
1,009 |
$16K |
| 96127 |
|
1,434 |
1,431 |
$15K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,162 |
1,157 |
$12K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
149 |
148 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
140 |
138 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
736 |
696 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
246 |
244 |
$4K |
| 87081 |
|
562 |
544 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
26 |
26 |
$3K |
| 81002 |
|
1,026 |
1,002 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
225 |
112 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
83 |
77 |
$3K |
| 87634 |
|
37 |
37 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
15 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
94 |
94 |
$2K |
| 83655 |
|
134 |
132 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
53 |
51 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| 92552 |
|
26 |
25 |
$673.92 |
| 99177 |
|
48 |
48 |
$569.28 |
| 80061 |
Lipid panel |
46 |
44 |
$568.06 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$447.08 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$447.08 |
| 92551 |
|
43 |
43 |
$426.99 |
| 87070 |
|
29 |
29 |
$387.48 |